← Eichor
Condition: Alcohol Associated Liver Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alcohol Associated Liver Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Li
Phase N/A · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07652892Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191LGG Supplementation in Patients With AUD and ALD
Phase 2 · 1 location(s) · University of Louisville · NCT05178069CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Phase 1 · 3 location(s) · GlaxoSmithKline · NCT07358546ADDICTOlogical Intervention in LIVEr Transplantation Recipients
NA · 16 location(s) · University Hospital, Montpellier · NCT06472973Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
Phase 2 · 6 location(s) · Samer Gawrieh · NCT07060638Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
NA · 3 location(s) · University of Wisconsin, Madison · NCT06305624Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Phase 3 · 84 location(s) · Bausch Health Americas, Inc. · NCT07428538Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
Phase 1/Phase 2 · 2 location(s) · Virginia Commonwealth University · NCT05548452RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated
Phase 2 · 43 location(s) · Altimmune, Inc. · NCT07009860Tirzepatide in MetALD
Phase 2 · 1 location(s) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NCT07046819Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers
Phase 1 · 1 location(s) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NCT04781322Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic He
NA · 1 location(s) · Bioaraba Health Research Institute · NCT05294744Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
NA · 1 location(s) · Henry Ford Health System · NCT06269510Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)
NA · 1 location(s) · Yale University · NCT07525258Short Course Steroids in Alcohol Associated Hepatitis
Phase 3 · 2 location(s) · Asian Institute of Gastroenterology, India · NCT06919458A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease
NA · 1 location(s) · The University of Hong Kong · NCT07450144A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · 23 location(s) · King's College London · NCT06461208
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.